Status:
UNKNOWN
[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse
Lead Sponsor:
Augusta University
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test the effectiveness of prophylactic mouth rinses in reducing the amount of viruses, specifically SARS-CoV-2 in the oral cavity. This research will guide dental and m...
Detailed Description
In response to SARS-CoV-2 the dental and greater healthcare communities have devised ways to combat the spread of the virus. Many dentists and physicians have advocated the use of prophylactic oral ri...
Eligibility Criteria
Inclusion
- Subject of both sexes, aged 18 years or older
- Patients who are confirmed positive for COVID-19.
- Patients currently hospitalized at Augusta University Medical Center.
- Subject voluntarily signing the informed consent document.
Exclusion
- Age younger than 18 years old.
- Patients that are tested negative for COVID-19
- Patient who are intubated or too sick to give consent for the study.
- Not able to speak in English or illiterate or lacking the decision-making capacity to consent for study.
- Known allergy to Listerine, Betadine or Chlorhexidine gluconate
Key Trial Info
Start Date :
October 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04719208
Start Date
October 6 2020
End Date
December 1 2023
Last Update
February 1 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Augusta University
Augusta, Georgia, United States, 30901
2
Augusta University-Dental College of Georgia
Augusta, Georgia, United States, 30912